Zhang Z, Zhang J, Dai S, Fan X, Liu Y, Sun J
BMC Infect Dis. 2024; 24(1):1405.
PMID: 39696007
PMC: 11654325.
DOI: 10.1186/s12879-024-10304-4.
Curci D, Braidotti S, Maximova N
Front Pharmacol. 2024; 15:1478381.
PMID: 39508043
PMC: 11537990.
DOI: 10.3389/fphar.2024.1478381.
Biswas N, Bahr A, Howard J, Bonin J, Grazda R, MacNamara K
Stem Cell Reports. 2024; 19(5):639-653.
PMID: 38608679
PMC: 11103789.
DOI: 10.1016/j.stemcr.2024.03.007.
Vanickova K, Milosevic M, Ribeiro Bas I, Burocziova M, Yokota A, Danek P
EMBO J. 2023; 42(23):e113527.
PMID: 37846891
PMC: 10690458.
DOI: 10.15252/embj.2023113527.
Cvetkovic Z, Pantic N, Cvetkovic M, Virijevic M, Sabljic N, Marinkovic G
Diagnostics (Basel). 2023; 13(18).
PMID: 37761258
PMC: 10527817.
DOI: 10.3390/diagnostics13182891.
Protection against lethal sepsis following immunization with species varies by isolate and inversely correlates with bone marrow tissue damage.
Lilly E, Bender B, Noverr M, Fidel P
Infect Immun. 2023; 91(10):e0025223.
PMID: 37702509
PMC: 10580931.
DOI: 10.1128/iai.00252-23.
Reconditioned monocytes are immunomodulatory and regulate inflammatory environment in sepsis.
Jain K, Mohan K, Roy G, Sinha P, Jayaraman V, Kiran
Sci Rep. 2023; 13(1):14977.
PMID: 37696985
PMC: 10495550.
DOI: 10.1038/s41598-023-42237-4.
How I treat cytopenias after CAR T-cell therapy.
Jain T, Olson T, Locke F
Blood. 2023; 141(20):2460-2469.
PMID: 36800563
PMC: 10646792.
DOI: 10.1182/blood.2022017415.
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy.
Sobrino S, Magnani A, Semeraro M, Martignetti L, Cortal A, Denis A
Cell Rep Med. 2023; 4(2):100919.
PMID: 36706754
PMC: 9975109.
DOI: 10.1016/j.xcrm.2023.100919.
The role of the microbiota in myelopoiesis during homeostasis and inflammation.
Kim Y, Kamada N
Int Immunol. 2023; 35(6):267-274.
PMID: 36694400
PMC: 10199171.
DOI: 10.1093/intimm/dxad002.
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy.
Rejeski K, Burchert A, Iacoboni G, Sesques P, Fransecky L, Bucklein V
Blood Adv. 2022; 6(16):4719-4725.
PMID: 35793454
PMC: 9631678.
DOI: 10.1182/bloodadvances.2022007776.
Antigen presentation safeguards the integrity of the hematopoietic stem cell pool.
Hernandez-Malmierca P, Vonficht D, Schnell A, Uckelmann H, Bollhagen A, Mahmoud M
Cell Stem Cell. 2022; 29(5):760-775.e10.
PMID: 35523139
PMC: 9202612.
DOI: 10.1016/j.stem.2022.04.007.
Microbial Sensing by Hematopoietic Stem and Progenitor Cells.
Barman P, Goodridge H
Stem Cells. 2022; 40(1):14-21.
PMID: 35511863
PMC: 9072977.
DOI: 10.1093/stmcls/sxab007.
Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromes.
Paracatu L, Monlish D, Greenberg Z, Fisher D, Walter M, Oh S
Exp Hematol. 2022; 110:47-59.
PMID: 35367529
PMC: 9590644.
DOI: 10.1016/j.exphem.2022.03.011.
Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer.
Chen C, Man N, Liu F, Martin G, Itonaga H, Sun J
Cancer Res. 2022; 82(11):2047-2056.
PMID: 35320354
PMC: 9177721.
DOI: 10.1158/0008-5472.CAN-21-3503.
Train the Trainer: Hematopoietic Stem Cell Control of Trained Immunity.
De Zuani M, Fric J
Front Immunol. 2022; 13:827250.
PMID: 35154147
PMC: 8828730.
DOI: 10.3389/fimmu.2022.827250.
Remodeling of the Bone Marrow Stromal Microenvironment During Pathogenic Infections.
Mun Y, Fazio S, Nombela Arrieta C
Curr Top Microbiol Immunol. 2021; 434:55-81.
PMID: 34850282
DOI: 10.1007/978-3-030-86016-5_3.
IL-18R-mediated HSC quiescence and MLKL-dependent cell death limit hematopoiesis during infection-induced shock.
Howard J, Smith J, Fredman G, MacNamara K
Stem Cell Reports. 2021; 16(12):2887-2899.
PMID: 34798063
PMC: 8693653.
DOI: 10.1016/j.stemcr.2021.10.011.
Progranulin signaling in sepsis, community-acquired bacterial pneumonia and COVID-19: a comparative, observational study.
Brandes F, Borrmann M, Buschmann D, Meidert A, Reithmair M, Langkamp M
Intensive Care Med Exp. 2021; 9(1):43.
PMID: 34476621
PMC: 8412980.
DOI: 10.1186/s40635-021-00406-7.
An Early Myelosuppression in the Acute Mouse Sepsis Is Partly Outcome-Dependent.
Skirecki T, Drechsler S, Jeznach A, Hoser G, Jafarmadar M, Kawiak J
Front Immunol. 2021; 12:708670.
PMID: 34367170
PMC: 8339578.
DOI: 10.3389/fimmu.2021.708670.